Atlas Trials

Fibroblast Growth Factor-23 (FGF-23) is Independently Associated With Left Ventricular Mass Index (LVMI) and Myocardial Performance Index (MPI) in Haemodialysis Patients

Clinical trial NCT01154842 · UNKNOWN

Trial details

NCT number
NCT01154842
Sponsor
Diskapi Teaching and Research Hospital
Status
UNKNOWN
Study type
OBSERVATIONAL
Fibroblast
Start date
2009-12-01
Primary completion
2010-05-01
Enrollment
128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.